Skip to main content

Advertisement

Table 5 Indication for biopsy in malignant cases (n = 133)

From: Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients

Indication for biopsy in malignant cases Reason for US/FNA not impacting on decision-making
Clinical suspicion (n = 68) No US performed (n = 63)
US inconclusive/not suspicious (n = 5)
No FNA performed (n = 19)
FNA results inconclusive/not suspicious/not awaited (n = 49)
Clinical and US suspicion (n = 61) No FNA performed (n = 5)
FNA results inconclusive/not suspicious/not awaited (n = 56)
Clinical suspicion and FNA C5 (n = 2) No US performed (n = 2)
FNA C3 result (n = 1)a No US performed (n = 1)
Clinical and US suspicion, FNA C5 (n = 1) Not applicable
  1. aNo clinical suspicion of malignancy
  2. Diagnostic findings that led to performing a confirmatory biopsy in patients with malignant disease (n = 133)